HPV Vaccine - Provider Resources

Fact Sheets:

  • A Quick Look at Using Human Papillomavirus Vaccines (HPV)  - Michigan Department of Community Health: This fact sheet for health care professionals includes sections on: Indications for Use and Schedule; Recommended Schedule; Vaccine Administration; Storage and Handling; Special Situations; Contraindications and; Precautions. (January 2012)

Provider Tools:

  • ACOG's Human Papillomavirus Vaccination Toolkit: This newly updated ACOG toolkit uses evidence-based, tested messages and other materials to help physicians and other health care professionals communicate with patients about the importance of receiving the HPV vaccine.

  • The American Cancer Society HPV VACS newsletter: This American Cancer Society Partner Newsletter is published monthly and provides key resources that are available for use and the latest news and studies on HPV vaccination.

  • Top 10 List for HPV: Top 10 ways to improve HPV Vaccination rates in your practice (Center for Disease Control)

  • Co-Branded Letter of HPV Vaccination Recommendation: Use this letter to make recommendations for patients to receive HPV vaccine; supported by the Michigan Department of Health and Human Serivces and leading health professional organizations in Michigan.

Provider Education:
  • "HPV Vaccination: Do Your Patients Get the Message?" (March, 2011 issue of Contemporary OB/GYN)
    Obstetricians/gynecologists can play a critically important role in helping prevent the morbidity and mortality associated with cervical cancer and other HPV-related diseases by helping educate adolescents, young adults, and the mothers of young women about safety, efficacy, and clinical recommendations to increase HPV vaccination rates. 

  • "Steps for Increasing HPV Vaccination in Practice" (ACS, 2015)
    An action guide to implement evidence-based strategies for clinicians; includes pediatricians, family physicians, general internists, obstetrician-gynecologists, nurse practitioners, physician assistants, nurses, medical assistants and their office managers.
  • "Use and Acceptance of HPV Vaccine Still a Work in Progress" (NCI Cancer Bulletin; May 3, 2011; Vol. 8 / No. 9)
    The Gardasil and Cervarix vaccines protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus, responsible for more than 70 percent of cervical cancer cases worldwide. This article discusses the issues with translation of basic research to the clinic. And highlights that in many respects, FDA approval is just the beginning.
  • Vaccine Safety: Human Papillomavirus (HPV) Vaccine – Center for Disease Control and Prevention
    This page features general information about the HPV vaccines licensed for use in the United States (Cervarix and Gardasil), as well as links to HPV vaccine safety studies, frequently asked questions about HPV vaccine safety, reports of fainting and other adverse events following vaccination, and related scientific articles.
  • American Social Health Association
    The American Social Health Association develops and offers accurate, medically reliable information about sexual health, including sexually transmitted diseases and infections
More information is available on these MCC pages: